Therefore, immunoliposomes exerted a systemic efficient activation of immune response, strengthening the tumor response, whereas this effect was not outperformed either by the chemotherapy or non-targeted liposomes alone or by the combination of LPD and free α-PD-L1. The gene discussed is CD274; the disease is neoplasm.